Kezar Life Sciences, Inc.KZRNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-84M

+17.8% YoY

Free Cash Flow

$-74M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	7	0
Gross Profit	-2	-2↑2.2%	0	7	0
Operating Income	-43	-55↓27.1%	-71↓30.2%	-111↓56.6%	-91↑18.7%
Net Income	-42	-55↓30.9%	-68↓24.9%	-102↓49.3%	-84↑17.8%
EBITDA	-40	-53↓31.6%	-66↓24.7%	-99↓50.3%	-81↑18.3%
EPS Diluted	-0.95	-1.04↓9.5%	-1.01↑2.9%	-1.40↓38.6%	-1.15↑17.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	21	63↑196.2%	40↓35.7%	35↓12.3%	42↑17.6%
Total Current Assets	145	212↑46.2%	286↑35.0%	207↓27.6%	137↓33.6%
Total Assets	152	218↑43.5%	300↑37.5%	221↓26.1%	145↓34.6%
Total Current Liabilities	6	8↑27.5%	11↑33.9%	18↑61.4%	20↑14.6%
Total Liabilities	11	21↑93.8%	30↑41.0%	34↑13.4%	28↓17.5%
Total Equity	141	197↑39.7%	270↑37.1%	188↓30.5%	117↓37.7%
Total Debt	5	14↑157.0%	21↑51.4%	19↓11.0%	16↓14.5%
Net Debt	-16	-49↓209.8%	-19↑60.7%	-17↑13.7%	-26↓54.4%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-37	-42↓14.9%	-59↓38.7%	-82↓38.7%	-74↑9.1%
Capital Expenditure	-0	-0↓62.9%	-2↓399.4%	-2↓14.7%	-0↑98.4%
Free Cash Flow	-37	-43↓15.1%	-60↓41.3%	-83↓38.1%	-74↑11.0%
Stock-Based Comp	5	8↑53.7%	14↑84.4%	18↑29.5%	13↓28.3%
Net Change in Cash	6	42↑563.6%	-22↓153.8%	-5↑77.9%	6↑226.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance